GenSight Biologics S.A.
GSGTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19,179 | $20,545 | $136,294 | $268,012 |
| - Cash | $2,464 | $2,134 | $10,610 | $44,288 |
| + Debt | $19,113 | $23,535 | $17,861 | $12,566 |
| Enterprise Value | $35,828 | $41,946 | $143,545 | $236,290 |
| Revenue | $1,500 | $1,267 | $2,582 | $5,276 |
| % Growth | 18.4% | -50.9% | -51.1% | – |
| Gross Profit | $1,500 | $1,267 | $2,582 | $5,276 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$11,369 | -$20,890 | -$26,774 | -$27,199 |
| % Margin | -757.9% | -1,648.8% | -1,036.9% | -515.5% |
| Net Income | -$14,001 | -$26,220 | -$27,624 | -$28,617 |
| % Margin | -933.4% | -2,069.5% | -1,069.9% | -542.4% |
| EPS Diluted | -0.17 | -0.54 | -0.6 | -0.63 |
| % Growth | 68.5% | 10% | 4.8% | – |
| Operating Cash Flow | -$12,937 | -$24,663 | -$33,753 | -$17,139 |
| Capital Expenditures | -$1 | -$10 | -$252 | -$32 |
| Free Cash Flow | -$12,938 | -$24,673 | -$34,005 | -$17,171 |